ArticleBMC gastroenterology2026
Trends and inequities in peptic ulcer mortality across the United States, 1999-2023.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundPeptic ulcer disease (PUD) remains a cause of gastrointestinal mortality despite advances in Helicobacter pylori eradication and gastroprotection.
methodsWe analyzed U.S. death certificates in CDC WONDER from 1999 to 2023, using Underlying Cause-of-Death files. Age-adjusted mortality rates (AAMRs; per 100,000) were standardized to the 2000 U.S. POPULATION: Trends used average annual percent change (AAPC). Analyses were stratified by sex, age, race/ethnicity, region, urban-rural status, and ICD-10 subtype (K25-K28).
resultsFrom 1999 to 2023, there were 87,574 PUD deaths. Annual deaths fell from 4,575 (1999) to 3,850 (2023; - 15.85%). AAMR declined from 3.30 (95% CI 3.20-3.39) to 1.78 (1.73-1.84) (AAPC - 2.66%, 95% CI - 3.80 to - 1.51). In 2023, AAMR was 2.09 (2.00-2.19) in males and 1.46 (1.39-1.52) in females; rates rose with age from 0.25 (35-44 years) to 14.71 (≥ 85 years). By race/ethnicity, AAMR was 1.81 (non-Hispanic [NH] White), 1.70 (NH Black), 1.57 (NH Other), and 1.47 (Hispanic). The West reached its highest point in 1999 and 2023. By 2013, NCHS (through 2020), the metropolitan AAMR was 1.74 (1.67-1.80) compared to 2.07 (1.91-2.23) in nonmetropolitan areas. Duodenal and gastric ulcers predominated; subtype AAPCs showed the steepest decline for unspecified-site ulcers.
conclusionsPUD mortality declined over a 25-year period but plateaued or increased in selected strata in the late 2010s and during the pandemic. Findings support sustained H. pylori control, evidence-based gastroprotection for high-risk medication users, and timely endoscopy-especially for older adults, men, rural residents, and regions with a high burden. Continuous surveillance should monitor post-pandemic rebound risks and equity in access.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.